Related Experiment Video
Updated: Sep 27, 2025
Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
Published on: June 12, 2018
Two-step formulation of magnetic nanoprobes for microRNA capture
Iveta Vilímová1, Igor Chourpa1, Stéphanie David1
1EA6295 Nanomédicaments et Nanosondes, Université de Tours Tours France katel.herve@univ-tours.fr.
Abstract:
MicroRNAs (miRs) belong to a family of short non-coding endogenous RNAs. Their over-expression correlates with various pathologies: for instance, miRNA-155 (miR-155) is over-expressed upon the development of breast cancers. However, the detection of miRs as disease biomarkers suffers from insufficient sensitivity. In the present study, we propose a protocol for a rapid and efficient generation of magnetic nanoprobes able to capture miR-155, with the aim of increasing its concentration. As a nanoprobe precursor, we first synthesized superparamagnetic iron oxide nanoparticles (SPIONs) coated with covalently attached polyethylene glycol carrying a free biotin terminus (PEG-bi). Using streptavidin-biotin interactions, the nanoprobes were formulated by functionalizing the surface of the nanoparticles with the miR sequence (CmiR) complementary to the target miR-155 (TmiR). The two-step formulation was optimized and validated using several analytical techniques, in particular with Size-Exclusion High Performance Liquid Chromatography (SE-HPLC). Finally, the proof of the nanoprobe affinity to TmiR was made by demonstrating the TmiR capture on model solutions, with the estimated ratio of 18 : 22 TmiR : CmiR per nanoprobe. The nanoprobes were confirmed to be stable after incubation in serum.
Insights
Researchers developed magnetic nanoprobes to capture microRNA-155 (miR-155), enhancing detection sensitivity for breast cancer biomarkers. This method efficiently concentrates target miRs for improved diagnostic potential.
Area of Science:
- Biotechnology
- Nanotechnology
- Molecular Biology
Background:
- MicroRNAs (miRs) are short non-coding RNAs implicated in various pathologies.
- Over-expression of microRNA-155 (miR-155) is associated with breast cancer development.
- Current methods for miR detection as biomarkers lack sufficient sensitivity.
Purpose of the Study:
- To develop a rapid and efficient protocol for generating magnetic nanoprobes.
- To create nanoprobes capable of capturing and concentrating miR-155.
- To enhance the sensitivity of miR-155 detection for potential biomarker applications.
Main Methods:
- Synthesis of superparamagnetic iron oxide nanoparticles (SPIONs) coated with biotinylated polyethylene glycol (PEG-bi).
- Functionalization of SPIONs with a complementary miR sequence (CmiR) via streptavidin-biotin interaction to create nanoprobes.
- Optimization and validation of the nanoprobe formulation using Size-Exclusion High Performance Liquid Chromatography (SE-HPLC).
Main Results:
- Successful synthesis and characterization of stable magnetic nanoprobes.
- Demonstrated affinity of nanoprobes for target miR-155 (TmiR) in model solutions.
- Estimated capture ratio of 18:22 TmiR:CmiR per nanoprobe, indicating efficient binding.
Conclusions:
- The developed magnetic nanoprobes offer a promising approach for capturing and concentrating miR-155.
- This method has the potential to improve the sensitivity of miR-155 detection for breast cancer diagnostics.
- The nanoprobes exhibit stability in serum, suggesting potential for in vivo applications.
